A preclinical trial of the reassortant influenza virus vaccinе strain A/17/Quail/Hong Kong/97/84 (H9N2)

In this work, we examined the reassortant influenza virus strain A/17/Quail/Hong Kong/97/84 (H9N2) prepared at the Virology Department, Institute of Experimental Medicine, Russian Academy of Medical Sciences. The A/Leningrad/134/17 (H2N2)-based vaccine candidate contained hemagglutinin and the neura...

Full description

Bibliographic Details
Main Authors: Yu. A. Desheva, T. A. Smolonogina, L. G. Rudenko
Format: Article
Language:English
Published: Central Research Institute for Epidemiology 2015-08-01
Series:Вопросы вирусологии
Subjects:
Online Access:https://virusjour.crie.ru/jour/article/viewFile/342/220